Following these proceedings, RBC Capital Mkts downgraded its Sangamo Therapeutics Inc [SGMO] rating to a Sector perform from a an Outperform in a research note published on November 03, 2023; the price target was decreased to $2 from $6. A number of analysts have revised their coverage, including BofA Securities’s analysts, who decreased its forecast for the stock in late April from “a Neutral” to “an Underperform”. Wedbush also remained covering SGMO and has increased its forecast on February 27, 2023 with a “an Outperform” recommendation from previously “Neutral” rating. BofA Securities revised its rating on January 06, 2023. It rated SGMO as “a Neutral” which previously was an “a Buy”.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Price Performance Review of SGMO
On Tuesday, Sangamo Therapeutics Inc [NASDAQ:SGMO] saw its stock fall -4.87% to $0.82. Over the last five days, the stock has lost -11.05%. Sangamo Therapeutics Inc shares have risen nearly 51.65% since the year began. Nevertheless, the stocks have risen 37.36% over the past one year. While a 52-week high of $1.48 was reached on 02/16/24, a 52-week low of $0.29 was recorded on 07/05/24. SMA at 50 days reached $0.8387, while 200 days put it at $0.6547.
Levels Of Support And Resistance For SGMO Stock
The 24-hour chart illustrates a support level at 0.7877, which if violated will result in even more drops to 0.7515. On the upside, there is a resistance level at 0.8646. A further resistance level may holdings at 0.9053. The Relative Strength Index (RSI) on the 14-day chart is 47.72, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0139, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.74%. Stochastics %K at 28.77% indicates the stock is a holding.
How much short interest is there in Sangamo Therapeutics Inc?
A steep rise in short interest was recorded in Sangamo Therapeutics Inc stocks on 2024-09-13, growing by 1.41 million shares to a total of 17.5 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 16.09 million shares. There was a rise of 8.06%, which implies that there is a positive sentiment for the stock.
